-
Please accept this email as a formal Freedom of Information request. 1.How many PCNs were issued on 09/01/26
Published: 10 June 2026
-
1. For the last 24 months, please could I have the number of PCNs issued for parking infringements at the John Radcliffe Hospital. Please could this data be broken down per month. a. For each month, how much money was collected from the PCNs?
Published: 10 June 2026
-
The Oxford University Hospitals NHS Foundation Trust is writing to respond to your request, Please see answers below: I would like to request the following information (via email , see email I sent this request as my preferred email address) regarding the maternity services: 1.The growth scan pathway from your hospital for the years 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024 and 2025. 2.The growth ultrasound scan pathway guidelines for the years 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024 and 2025. 3.The induction of labour guidelines for the years 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024 and 2025.
Published: 2 June 2026
-
Dear FOI Team, This is a request for information under the Freedom of Information Act 2000. I am a doctoral researcher studying the provision of menopause care (as per NICE definition: ‘menopause care is described as the identification, assessment, support and management of menopause and its associated symptoms') for people treated for breast cancer within NHS services. I would be grateful if you could provide the information below as recorded by your Trust. 1. Policy and pathways 1a. Does your Trust have a written policy, guideline, or clinical pathway addressing menopause symptoms in patients treated for breast cancer? Yes / No If yes, please provide the document or a web link. 1b. Is menopause care for breast cancer patients addressed within: a) Breast cancer service guidelines b) Oncology service guidelines c) Menopause service guidelines d) Not formally addressed 2. Service provision 2a. Does your Trust provide specialist menopause support specifically for patients with a history of breast cancer? Yes / No 2b. If yes, which of the following are available? (Please tick all that apply) Dedicated menopause clinic Joint oncology–gynaecology clinic Breast cancer nurse–led service Referral to general menopause clinic External referral only 3. Staffing and expertise 3a. Are any of the following routinely involved in menopause management for breast cancer patients? Breast care nurses Oncologists Gynaecologists GPs with special interest in menopause Menopause specialist nurses Sexual health specialist (including clinician/oncologist trained in sexual health and wellbeing) Other, please specify......................... 3b. Does your Trust provide specific training or education on menopause management in breast cancer patients for clinical staff? Yes / No 4. Patient information and support Does your Trust provide written or digital patient information, other than publicly available information, specifically addressing menopause symptoms after breast cancer treatment? Yes / No If yes, please provide copies or links. 5. Data collection and audit 5a. Does your Trust routinely collect or audit data on menopause symptoms or menopause-related quality of life in breast cancer patients? Yes / No 5b. Has your Trust conducted any audit, service evaluation, or quality improvement project related to menopause care in breast cancer patients in the last 3 years? Yes / No If yes, please provide the title and date. If any part of this request exceeds the cost limit, I would be grateful if you could advise how it may be refined
Published: 2 June 2026
-
Under the FOI act please can you confirm the following: 1. Please confirm if you operate a vendor management system for agency staff such as an MSP/neutral vendor/master vendor etc. If so, please can you name the below: -Company name -Contract start and end date -Framework utilised -Healthcare specialty used for, EG Doctors/Nursing/AHP/HSS/NMNC -Do you utilise a direct engagement model and the name of the model, eg Tempre/Own DE model etc Please confirm if you operate a vendor management system for bank staff. If so, please can you name the below: -Company name -Contract start and end date -Framework utilised -Healthcare specialty used for, EG Doctors/Nursing/AHP/HSS/NMNC
Published: 2 June 2026
-
Dear FOI team, I would like to request the following information: AI system information 1. How many artificial intelligence (AI) systems does your trust/health board currently have in development and what is the name of the AI system? 2. How many AI systems are currently deployed within your trust/health board and what is the name of the AI system? 3. For every AI model currently being used or developed in your trust: 3a. Is the AI model being used operationally, clinically, or for another purpose? 3b. What department(s) is the AI system being used in? 3c. What month and year was the AI system first deployed? (n/a if in development). 3d. Was the AI system created by a commercial entity, university, in-house, or within another NHS trust? Please give the name of the organisation. 3e. What is the AI systems architecture? (e.g. deep neural network, random forest, logistic regression, large language model). 3f. Which coding language and packages are used to deploy the AI system? (e.g. python - scikit-learn, pytorch, tensorflow) 3g. What is the nature of the input of the AI system? (e.g. a medical scan, free text notes, tables of lab results). 3h. What is the nature of the output of the AI system? (e.g. a masked image, a risk score, natural text). 3i. How was the AI system validated in the target population before deployment? 3j. What measures are in place to monitor for degradation in the performance of the AI system post-deployment? 3k. What was the cost to procure the AI model and what is the ongoing cost of use? 3l. Which departmental budget is the cost paid from? Data management 4. Was any local patient data used for training or fine tuning the AI system? 5. Is any patient data collected specifically for the purpose of training any of the AI systems currently in development or deployment? 6. Do you share, or plan to share, any patient data with third-party developers for AI-related purposes? If yes, please provide details of the data-sharing agreement or relevant policy. Regulation 7. What is the regulation and certification of the AI model under the European Union Medical Device Directive and/or United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA)? Patient/public involvement 8. Was any patient/public engagement undertaken before deployment of the AI system? 9. Is there any ongoing patient/public engagement input into the use of AI within your organisation? Governance 10. Who has responsibility for the AI systems being using? 11. Does your organisation have a governance policy that covers: 11a. Use of AI systems within your organisation? 11b. Ongoing evaluation of an AI model's performance after deployment? 11c. How to monitor for bias in the AI system and how to mitigate against this?
Published: 2 June 2026
-
1. AI leadership Does the trust have named leaders for clinical AI tool evaluation and implementation? If so, please provide their names, NHS job titles and NHS email addresses? 2. AI Strategy and Planning Does the trust have an artificial intelligence (AI) strategy, roadmap, or equivalent strategic document? If yes, please provide a copy or link. 3. AI Policies Does the trust have approved policies specific to the development, procurement, or use of AI tools? If yes, please provide copies. 4. Governance and Oversight Does the trust have a dedicated governance committee or formal mechanism reviewing AI initiatives for ethical and safety considerations? If yes, does it include clinical representation? 5. Use of AI in Clinical Care Is the trust currently using AI tools in clinical care? If yes, does the trust conduct regular audits and use standardised methodologies (e.g. dashboards) to assess financial, clinical, and operational impact? 6. AI Literacy and Training Does the trust offer AI literacy or skills training for the following staff groups? Please indicate yes/no and provide brief details. (a) Clinical staff (b) Technical staff (e.g. clinical scientists) (c) Operational staff (e.g. secretaries, MDT coordinators and managers).
Published: 2 June 2026
-
Dear FOI Team, 1. I would like to enquire if Oxford University Hospitals NHS Foundation Trust uses a specific Venous thromboembolism (VTE) prophylaxis guideline/risk assessment tool for patients on critical/intensive care units. If this exists, please could you send me a copy via email. Thank you for your help,
Published: 2 June 2026
-
Dear Freedom of Information Officer, I am writing to make a request under the Freedom of Information Act 2000. Please provide the following information from the financial years 2020/2021 to the end of the financial year 2025/2026: 1)The total number of patients aged under 21 who presented, or were referred within your organisation with a diagnosis or suspected diagnosis of an asbestos-related disease, including but not limited to: mesothelioma, asbestosis, pleural plaques, pleural effusion attributed to asbestos exposure, or diffuse pleural thickening. 2)Please break this figure down by financial year. Where the number of cases in any given year is five or fewer, please state "<5" rather than the exact figure. 3)Please confirm whether your organisation holds any coded data for these conditions in patients aged under 21, even if no cases have been recorded during the period. If you do not hold this information, please confirm that is the case and, where possible, advise which body may hold it. I am happy to receive this information in any electronic format. If you require clarification to process this request, please contact me at the address below.
Published: 2 June 2026
-
Dear Freedom of Information Team, I am making this request under the Freedom of Information Act 2000. Please provide the following information held by Royal Free London NHS Foundation Trust in relation to FDG brain PET imaging performed on the PET scanner. A set of approximately 40 fully anonymised FDG brain PET DICOM studies acquired on the PET scanner, preferably from adult patients aged 22–48 whose scans were reported as normal. For clarity, I am not requesting identifiable patient records. I am requesting only data that has been anonymised so that no patient is identifiable. Kind regards, Andy Benjamin
Published: 26 May 2026
